Panbela Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Panbela Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2011 to Q3 2024.
  • Panbela Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 4.85M shares, a 62% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 4.85M +1.86M +62% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 4.85M +2.24M +85.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 4.85M -11.2M -69.8% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 480K +478K Dec 31, 2023 10-Q 2024-11-14
Q3 2023 3M -17.8M -85.6% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 2.61M -18.2M -87.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 16.1M +2.64M +19.6% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 1.74K* -334K Dec 31, 2022 10-K 2024-03-26
Q3 2022 20.8M +7.36M +54.8% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 20.8M +10.7M +106% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 13.4M +3.36M +33.3% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 336K -9.33M -96.5% Dec 31, 2021 10-K 2023-03-16
Q3 2021 13.4M +3.78M +39.2% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 10.1M +3.03M +42.8% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 10.1M +3.46M +52.1% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 9.66M +3.03M +45.7% Dec 31, 2020 10-K 2022-03-24
Q3 2020 9.65M +3.03M +45.7% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 7.07M +1.35M +23.5% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 6.63M +1.56M +30.8% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 6.63M +1.55M +30.6% Dec 31, 2019 10-K 2021-03-25
Q3 2019 6.62M +1.56M +30.9% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 5.72M +662K +13.1% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 5.07M +976K +23.9% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 5.08M +1.24M +32.2% Dec 31, 2018 10-K 2020-03-24
Q3 2018 5.06M +1.39M +37.9% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 5.06M -31.6M -86.2% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 4.09M -32.3M -88.8% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 3.84M +622K +19.3% Dec 31, 2017 10-K 2019-03-22
Q3 2017 3.67M -28.5M -88.6% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 36.7M +4.82M +15.1% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 36.4M +6.5M +21.7% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 3.22M -26.7M -89.2% Dec 31, 2016 10-K 2018-03-21
Q3 2016 32.2M +2.26M +7.56% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 31.9M +30.4M +2098% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 29.9M +28.5M +1964% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 29.9M +24.2M +425% Dec 31, 2015 10-K 2017-03-30
Q3 2015 29.9M +28.4M +1961% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 1.45M 0 0% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 1.45M 0 0% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 5.69M +4.24M +292% Dec 31, 2014 10-K 2016-03-08
Q3 2014 1.45M 0 0% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 1.45M 0 0% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 1.45M 0 0% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 1.45M 0 0% Dec 31, 2013 10-K 2015-03-30
Q3 2013 1.45M Sep 30, 2013 10-Q 2013-11-14
Q2 2013 1.45M Jun 30, 2013 10-Q 2013-08-14
Q1 2013 1.45M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 1.45M 0 0% Dec 31, 2012 10-K 2014-03-28
Q4 2011 1.45M Dec 31, 2011 10-K 2013-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.